How Much Does Lyme Disease Cost Patients and Society?

Lyme disease can create substantial medical and productivity costs
Patients with persistent symptoms often face the greatest financial burden
Studies suggest the economic impact reaches billions of dollars annually

Short answer: Studies have estimated that Lyme disease costs patients, families, and society hundreds of millions to billions of dollars annually through medical expenses, lost productivity, disability, travel costs, and persistent symptoms following treatment.

How much does Lyme disease cost patients and society? Researchers have examined the financial burden of Lyme disease and found that costs extend far beyond physician visits and medications. Medical expenses, lost productivity, disability, travel, and persistent symptoms can create a substantial economic burden for patients, families, employers, and healthcare systems.

How Much Does Lyme Disease Treatment Cost?

The cases were identified based on physicians’ determinations in the medical record, patients’ clinical findings, tick exposure, and other relevant details including laboratory results. The mean costs of early Lyme disease consisted of $801 for direct medical costs, $259 for indirect medical costs, $52 for non-medical costs, and $196 for productivity costs. [1]

Key finding: Early Lyme disease was associated with an average annual cost of approximately $1,310 per patient, while chronic manifestations of Lyme disease were associated with average annual costs of $16,199 per patient, according to Zhang and colleagues. [1]

The cost of Lyme disease was even greater for individuals with chronic manifestations of the disease. The mean annual cost for these patients was $16,199. Costs consisted of $1,872 for direct medical costs, $434 for indirect medical costs, $5,109 for non-medical costs, and $8,785 for productivity losses. [1]

How Does Lyme Disease Compare With Other Chronic Illnesses?

The annual per-patient cost of chronic manifestations of Lyme disease was higher than the cost reported for several other chronic illnesses, including rheumatoid arthritis ($10,716), fibromyalgia ($10,911), and lupus ($13,094). [2,3]

Why Are Lyme Disease Costs So High?

The cost of Lyme disease extends beyond medical bills. Expenses may include physician visits, laboratory testing, medications, travel, reduced work productivity, disability, caregiving needs, and other non-medical costs.

Patients with persistent symptoms often face the greatest financial burden because costs may continue for months or years after the initial infection.

The Financial Impact of Post-Treatment Lyme Disease Syndrome (PTLDS)

A study by Aucott and colleagues confirmed the high number of Lyme disease cases with chronic manifestations, as described by Zhang. Thirty-six percent of individuals treated with 3 weeks of doxycycline for an erythema migrans rash suffered from Post-Treatment Lyme Disease Syndrome (PTLDS). [4]

“At 6 months, 36% of patients reported new-onset fatigue, 20% widespread pain, and 45% neurocognitive difficulties,” according to Aucott from Johns Hopkins University School of Medicine. “Patients who developed PTLDS had significantly lower life functioning compared to those without PTLDS.” [4]

What Is the Economic Impact of Lyme Disease in the United States?

The cost of Lyme disease to society is substantial. After reviewing 23,763 cases reported to the Centers for Disease Control and Prevention (CDC) in 2002, Zhang and colleagues found the financial impact of Lyme disease to be significant.

“The estimated nationwide annual economic impact of LD and relevant complaints was ≈$203 million (in 2002 dollars),” according to Zhang. [1]

Zhang suggested that the cost of Lyme disease would be considerably higher if the actual number of cases exceeded the reported case count. The CDC now estimates there are at least 300,000 new Lyme disease cases annually in the United States.

Could Lyme Disease Cost Society Billions of Dollars?

If the costs described by Zhang are extrapolated using current CDC estimates and the PTLDS rates reported by Aucott, the economic burden of Lyme disease could exceed $2 billion annually.

Math:

Number of early and chronic/late Lyme disease cases:

64% × 300,000 cases of early Lyme disease = 192,000

36% × 300,000 cases of chronic/late Lyme disease = 108,000

Cost of Lyme disease to individuals based on the Zhang study:

Early Lyme disease = $1,310

Chronic/late Lyme disease = $16,199

Estimated cost of Lyme disease to society:

$1,310 × 192,000 ≈ $251 million (early Lyme disease)

$16,199 × 108,000 ≈ $1.75 billion (chronic/late Lyme disease)

Zhang also suggested that the true cost of Lyme disease may be even higher because some costs were not included in the original analysis. Costs incurred beyond the study period were not captured. [1]

A study by Weitzner and colleagues reported that 11% of individuals suffered from PTLDS for more than a decade after treatment for culture-confirmed early Lyme disease. [6]

The actual financial burden for patients who remain ill for decades remains unknown. Both women (12.3%) and men (9.9%) were affected by PTLDS more than a decade after diagnosis. [6]

In addition, studies do not fully capture the impact of pain, suffering, lost opportunities, and reduced quality of life experienced by some patients with persistent symptoms.

Frequently Asked Questions

How much does Lyme disease treatment cost?

Costs vary depending on disease severity and duration. Studies have found that patients with persistent symptoms may incur substantially higher costs than patients treated successfully in the early stages of Lyme disease. [1]

Why is Lyme disease expensive for some patients?

Costs may include medical care, medications, travel, lost work productivity, disability, and long-term symptom management. Persistent symptoms often contribute significantly to the overall financial burden.

Does PTLDS increase healthcare costs?

PTLDS may contribute to higher healthcare costs because patients can experience ongoing fatigue, pain, and cognitive difficulties that require additional medical evaluation and treatment. [4]

What is the economic impact of Lyme disease in the United States?

Researchers have estimated that Lyme disease costs society hundreds of millions to billions of dollars annually when medical expenses, productivity losses, and persistent illness are considered. [1]

Clinical Perspective

Economic analyses consistently demonstrate that Lyme disease imposes a substantial burden on patients and society. While many individuals recover following treatment, others experience persistent symptoms that may lead to ongoing medical expenses and productivity losses.

Studies examining PTLDS suggest that the long-term financial impact of Lyme disease may be considerably greater than originally estimated.

Clinical Takeaway

Lyme disease creates a significant economic burden for both patients and society. While early Lyme disease is associated with lower costs, persistent symptoms and PTLDS can lead to substantially greater medical expenses, productivity losses, and quality-of-life impacts. These findings highlight the importance of timely diagnosis, effective treatment, and continued research into patients who remain ill after standard therapy.

Related Articles

What is Post-Treatment Lyme Disease Syndrome (PTLDS)?
Persistent Lyme Disease Symptoms
Recovery From Lyme Disease
Lyme Disease Symptoms Guide

References

1. Zhang X, Meltzer MI, Pena CA, Hopkins AB, Wroth L, Fix AD. Economic impact of Lyme disease. Emerg Infect Dis. 2006;12(4):653-660.
2. Silverman S, Dukes EM, Johnston SS, Brandenburg NA, Sadosky A, Huse DM. The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin. 2009;25(4):829-840.
3. Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum. 1993;36(11):1548-1559.
4. Aucott JN, Rebman AW, Crowder LA, Kortte KB. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Qual Life Res. 2013;22(1):75-84.
5. Steere AC, Sikand VK, Schoen RT, Nowakowski J. Asymptomatic infection with Borrelia burgdorferi. Clin Infect Dis. 2003;37(4):528-532.
6. Weitzner E, Visintainer P, Wormser GP. Comparison of males versus females with culture-confirmed early Lyme disease at presentation and at 11-20 years after diagnosis. Diagn Microbiol Infect Dis. 2016.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention